CVE-2023-38956Not scoredCWE-22

CVE-2023-38956: Zkteco Bioaccess Ivs vulnerability

Zkteco · Bioaccess Ivs

Affected: Zkteco Bioaccess Ivs · Exploitation: unlikely (under 1%)

Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.

0.7%probability of exploitation in the next 30 days

54th percentile

050100

Higher than 54% of scored CVEs

Not scored yet. The CVE record carries no CVSS score.

DescriptionCVE.org

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

On the Atlas

Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.

Open the Atlas

Exploitation: Unlikely (under 1%). EPSS under 1%, or no score yet.
CISA KEV: Not listed
Public check: No public nuclei template
Weakness: Path Traversal · File and Path Handling
Vendor: Zkteco
Published: August 2023
Band: Unlikely (under 1%), August 2023

CoverageNo articles yet

No CyberSIXT article names CVE-2023-38956 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.